PACB(Pacific Biosciences of California, Inc.) · 财务报表

PACB(Pacific Biosciences of California, Inc.) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$130.51M$128.30M$200.52M$154.01M$160.00M
毛利润$58.86M$49.03M$52.78M$37.28M$45.78M
营业利润−$210.44M−$307.20M−$334.47M−$474.31M−$553.86M
净利润−$181.22M−$314.25M−$306.74M−$309.85M−$546.38M
经营现金流−$111.18M−$263.21M−$259.17M−$206.06M−$111.21M
自由现金流−$117.11M−$279.96M−$268.02M−$212.25M−$113.92M
摊薄每股收益$-0.89$-1.40$-1.21$-1.59$-1.82

Pacific Biosciences of California, Inc. PACB